Alpha 2.0
Login Register
» Articles » PMID: 21540907

Ketamine-induced Cholangiopathy: a Case Report

Overview
Journal Am J Gastroenterol
Specialty Gastroenterology
Date 2011 May 5
PMID 21540907
Citations 9
Authors
Wai-Kay Seto
Matthew Ng
Pierre Chan
Irene Oi-Lin Ng
Stephen Chi-Wai Cheung
Ivan Fan-Ngai Hung
Man-Fung Yuen
Ching-Lung Lai
Affiliations
Soon will be listed here.
Citing Articles

Ketamine-Induced Sclerosing Cholangitis Associated With Early Inflammatory Bowel Disease During Chronic Topical Ketamine Use.

Lake-Bakaar G, Milgrom B, Kulig C, Sotelo A, Speirs J, Meihofer A Gastro Hep Adv. 2024; 3(4):471-473.

PMID: 39131718 PMC: 11308429. DOI: 10.1016/j.gastha.2024.02.004.

Features of biliary tract diseases in ketamine abusers: a systematic review of case reports.

Teymouri A, Nasoori H, Fakheri M, Nasiri A J Med Case Rep. 2024; 18(1):84.

PMID: 38431685 PMC: 10909254. DOI: 10.1186/s13256-024-04421-6.

Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature.

Bauer U, Pavlova D, Abbassi R, Lahmer T, Geisler F, Schmid R Clin J Gastroenterol. 2022; 15(6):1124-1129.

PMID: 35953614 PMC: 9371366. DOI: 10.1007/s12328-022-01687-5.

Bile Duct Injury due to Drug Induced Liver Injury.

Grewal P, Ahmad J Curr Hepatol Rep. 2020; 18(3):269-273.

PMID: 33134030 PMC: 7597665. DOI: 10.1007/s11901-019-00474-0.

Long-Term Outcomes After Drug-Induced Liver Injury.

Hayashi P, Bjornsson E Curr Hepatol Rep. 2019; 17(3):292-299.

PMID: 30666283 PMC: 6337717. DOI: 10.1007/s11901-018-0411-0.